title: A shield against a monster: Hepatitis C in hemodialysis patients.
abstract: Hepatitis C virus (HCV) infection is highly prevalent among patients on hemodialysis (HD). The prevalence of HCV infection in HD patients varies markedly from country to country. Some factors are especially related to these high prevalence rates, such as blood transfusions and length of dialysis time. Nosocomial routes of transmission including the use of contaminated equipment and patient-to-patient exposure is considered more important. Several prophylactic measures have been suggested to avoid infection by HCV in the HD environment.
authors.forename: Seyed-Moayed
authors.initials: SM
authors.lastname: Alavian
mesh_terms: D003020:Clothing / Q000592:standards; D004203:Disinfection / Q000592:standards; D005060:Europe / Q000453:epidemiology; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D015994:Incidence; D008017:Life Expectancy; D015995:Prevalence; D006435:Renal Dialysis / Q000592:standards*; D065227:Transfusion Reaction; D014481:United States / Q000453:epidemiology